Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2025 Jan 28;25(1):166.
doi: 10.1186/s12885-025-13577-3.

Correction: EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis

Ao Liu  1 , Xiaoming Wang  2 , Lian Wang  2 , Han Zhuang  2 , Liubo Xiong  2 , Xiao Gan  2 , Qian Wang  2 , Guanyu Tao  2
Affiliations
Published Erratum

Correction: EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis

Ao Liu et al. BMC Cancer. .
No abstract available

PubMed Disclaimer

Figures

Fig. 3
Fig. 3
Pooled estimates of the network meta-analysis. A: Pooled hazard ratios (95% confidence intervals) for progression-free survival (lower triangle) and overall survival (upper triangle) in patients with advanced EGFR-mutated NSCLC. B: Pooled risk ratios (95% confidence intervals) for objective response rate (lower triangle) and grade ≥ 3 adverse events (upper triangle) in patients with advanced EGFR-mutated NSCLC. The data in each cell represent hazard or risk ratios (95% confidence intervals) comparing the treatment defined in the column with the treatment defined in the row. Significant results are indicated in bold
Fig. 3
Fig. 3
Pooled estimates of the network meta-analysis. A: Pooled hazard ratios (95% confidence intervals) for progression-free survival (lower triangle) and overall survival (upper triangle) in patients with advanced EGFR-mutated NSCLC. B: Pooled risk ratios (95% confidence intervals) for objective response rate (lower triangle) and grade ≥ 3 adverse events (upper triangle) in patients with advanced EGFR-mutated NSCLC. The data in each cell represent hazard or risk ratios (95% confidence intervals) comparing the treatment defined in the column with the treatment defined in the row. Significant results are indicated in bold
See this image and copyright information in PMC

Erratum for

References

    1. Liu A, Wang X, Wang L et al. EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis. BMC Cancer. 2024;24:1390. 10.1186/s12885-024-13168-8. - PMC - PubMed

Publication types

LinkOut - more resources